Virtual Tumor Board: Multidisciplinary Management of Advanced Soft Tissue Sarcoma
Tracking # 20-1098480
What you'll learn
Upon completion of this activity, participants should be able to
- Distinguish patient and tumor characteristics that can inform personalized therapeutic approaches in soft tissue sarcoma
- Evaluate emerging data on novel therapies for soft tissue sarcoma
- Appraise multidisciplinary strategies to optimize treatment outcomes of patients with advanced soft tissue sarcoma
Course overview
Sarcomas, which represent 1% to 2% of adult cancers, are a rare, heterogeneous group of neoplasms originating in the connective tissue. Soft tissue sarcomas, which begin in the muscle, tendons, fat, lymph, blood vessels, and nerves, encompass more than 80 histological subtypes. Approximately 25% of patients develop metastatic disease after curative-intent surgery, and for these patients, treatment options are limited and prognosis is very poor. In recent decades, the identification of genetic alterations in soft tissue sarcoma has led to the rise of targeted therapy, significantly expanding the therapeutic landscape. Remaining up to date on pathological characteristics and emerging data on novel therapies is crucial (Riskjell et al, 2023; NCI, 2023). In this Virtual Tumor Board, Shreyaskumar R. Patel, MD, Medical Director of the Sarcoma Center at the University of Texas MD Anderson Cancer Center; Kathleen Polson, NP, Nurse Practitioner at Dana-Farber Cancer Institute; and Brian Rubin, MD, PhD, Professor of Pathology at Cleveland Clinic Cancer Center, will present cases and explore multidisciplinary strategies to optimize treatment outcomes for patients with advanced soft tissue sarcoma.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Practitioner
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
Registered Nurse Practitioner
Bahamas Medical Council
Medical Practitioner
District of Columbia Board of Nursing
Clinical Nurse Specialist
Licensed Practical Nurse
Nurse Practitioner
Registered Nurse
Florida Board of Nursing - Certified Nursing Assistants
Certified Nursing Assistant
Georgia Board of Nursing
Licensed Practical Nurse
Registered Professional Nurse
Kansas State Board of Nursing
Clinical Nurse Specialist
Licensed Practical Nurse
Nurse Practitioner
Registered Nurse
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
Mississippi State Board of Medical Licensure
Medical Doctor
Physician Assistant
New Hampshire Board of Medicine
Physician
New Hampshire Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
New Mexico Board of Nursing
Certified Nurse Practitioner
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
North Dakota Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Tennessee Board of Medical Examiners
Medical Doctor
Wyoming Board of Nursing
Certified Nurse Practitioner
Certified Nurse Specialist
Certified Nursing Assistant
Certified Registered Nurse Anesthetist
Licensed Practical Nurse
Registered Nurse
Disclosure statements
DISCLOSURE OF RELEVANT FINANCIAL INFORMATION WITH INELIGIBLE COMPANIES
i3 Health endorses the standards of the ACCME and ANCC that require everyone in a position to control the content of a CME/NCPD activity to disclose all financial relationships with ineligible companies that are related to the content of the CME/NCPD activity. CME/NCPD activities must be balanced, independent of commercial bias, and promote improvements or quality in health care. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.
A conflict of interest is created when an individual has an opportunity to affect CME/NCPD content about products or services of a commercial interest with which he/she has a financial relationship, which therefore may bias their opinions and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks, or other financial benefits.
i3 Health will identify, review, and mitigate all conflicts of interest that speakers, authors, or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. i3 Health does not endorse any products or services.
Relevant financial relationships exist between the following individuals and commercial interests:
The i3 Health planners, reviewers, and managers have nothing to disclose.
Shreyaskumar R. Patel, MD, has no relevant financial relationships to disclose.
Kathleen Polson, NP, has served as a consultant for Deciphera.
Brian P. Rubin, MD, PhD, has no relevant financial relationships to disclose.
i3 Health has mitigated all relevant financial relationships.
Take it Here
- This course reports to CE Broker immediately upon completion.
- Complete all courses at your own pace online.
- Quality and enjoyable courses.
- Modern experience, accessible from any device.
- All courses affordably priced.